These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 334609)

  • 1. Butacote and naproxen: a comparison of effectiveness in rheumatoid arthritis.
    Million R
    J Int Med Res; 1977; 5 Suppl 2():77-80. PubMed ID: 334609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butacote and ibuprofen: a comparative assessment in rheumatic diseases in general practice.
    Regalado RG
    J Int Med Res; 1977; 5 Suppl 2():70-6. PubMed ID: 334608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.
    Chlud K; Pangerl S
    Pharmatherapeutica; 1985; 4(2):113-21. PubMed ID: 3903778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butacote: the first assessment in general practice.
    Rushford WA; Fowler PD
    J Int Med Res; 1977; 5 Suppl 2():67-9. PubMed ID: 334607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric coated naproxen; a double blind trial comparing the tolerance of enteric coated and standard formulations.
    Huskisson EC; Bernstein RM; Coppock JS; Davies PG; Doyle DV; Platt PR; Scott DL; Witherington RH; Wojtulewski JA
    Eur J Rheumatol Inflamm; 1992; 12(2):27-30. PubMed ID: 1364935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis.
    Mizushima Y; Shiokawa Y; Honma M; Kageyama T
    Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of Butacote and naproxen in ankylosing spondylitis.
    Ansell BM
    J Int Med Res; 1977; 5 Suppl 2():95. PubMed ID: 334610
    [No Abstract]   [Full Text] [Related]  

  • 9. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoprofen compared with naproxen and placebo in rheumatoid arthritis.
    Berry H; Fernandes L; Clarke AK; Hamilton EB; Davies J; Dixon AS
    Eur J Rheumatol Inflamm; 1981; 4(1):87-92. PubMed ID: 7042367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Butacote: a six-year follow-up of patients with gastric intolerance to other medications.
    Cardoe N; Fowler PD
    J Int Med Res; 1977; 5 Suppl 2():59-66. PubMed ID: 334606
    [No Abstract]   [Full Text] [Related]  

  • 12. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
    Khan FM
    Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled comparative trial of Butacote and fenclofenac in the treatment of ankylosing spondylitis.
    Thompson M; Akyol MS
    J Int Med Res; 1977; 5 Suppl 2():96-9. PubMed ID: 334611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diflunisal compared with naproxen in chronic polyarthritis. Double-blind study].
    Baumgartner H; Boyle CM
    Schweiz Med Wochenschr; 1982 Feb; 112(8):281-5. PubMed ID: 7043728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind crossover study to evaluate the efficacy of a single daily dose of naproxen in rheumatoid arthritis.
    Katona G; Vargas RB
    Eur J Rheumatol Inflamm; 1983; 6(3):233-41. PubMed ID: 6391928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter comparison of naproxen and indomethacin in rheumatoid arthritis.
    Castles JJ; Moore TL; Vaughan JH; Bolzan JA; Lee M; Lidsky MD; Caldwell JR; Ehrlich GE; Sharp JT; Kaye R
    Arch Intern Med; 1978 Mar; 138(3):362-6. PubMed ID: 343743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of Butacote and Naprosyn in ankylosing spondylitis.
    Ansell BM; Major G; Liyanage SP; Gumpel JM; Seifert MH; Mathews JA; Engler C
    Ann Rheum Dis; 1978 Oct; 37(5):436-9. PubMed ID: 363071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical results of a multicentral double-blind examination of naproxen compared to indomethacin in chronic rheumatoid arthritis, ankylosing spondylitis, and osteoarthrosis].
    Aeidler H
    Arzneimittelforschung; 1975 Feb; 25(2A):315-8. PubMed ID: 1096903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method].
    Brooks PM; Walker JJ; Lee P; Bell AM; Buchanan WW; Fowler PD; Anderson JA
    Z Rheumatol; 1975; 34(9-10):350-65. PubMed ID: 1106038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meclofenamate sodium, phenylbutazone, and naproxen in the treatment of degenerative joint disease. Report of a placebo-controlled double-blind clinical comparison.
    López Sánchez J; Yañez Marchena G
    Arzneimittelforschung; 1983; 33(4A):653-6. PubMed ID: 6349651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.